Literature DB >> 21858536

The expression and clinical significance of CLIC1 and HSP27 in lung adenocarcinoma.

Wei Wang1, Xin Xu, Wujun Wang, Wenlong Shao, Liping Li, Weiqiang Yin, Liangchang Xiu, Mingcong Mo, Jin Zhao, Qingyu He, Jianxing He.   

Abstract

The purpose of this research was to study the roles of chloride intracellular channel protein 1 (CLIC1) and heat shock protein 27 (HSP27) in the clinical pathology of lung adenocarcinoma and to explore whether the expression of CLIC1 and HSP27 can be used as independent factors for the prediction of recurrence and prognosis after radical resection of lung adenocarcinoma. One hundred and three paraffin sections of lung adenocarcinoma tissues were collected, and the expression of CLIC1 and HSP27 was detected in these tumors using immunohistochemistry. The correlation of the expression of these two proteins with clinicopathological parameters and prognosis was statistically analyzed. In the 103 samples, the expression of HSP27 and CLIC1 was strongly positive in 61 (59.2%) and 49 cases (47.6%), respectively. Statistical analysis showed that the expression level of HSP27 did not significantly correlate with the patient's age, sex, degree of tumor differentiation, T staging of tumors, and TNM staging of tumors (p > 0.05), whereas the expression of CLIC1 did significantly correlate with T staging of tumors (p = 0.029). Univariate analysis indicated that the patient's ECOG score, T staging, N staging, TNM staging, and CLIC1 expression correlated with prognosis (p = 0.031, 0.001, 0.011, 0.013, and <0.001, respectively). Multivariate statistical analysis showed that age, T staging, and CLIC1 expression were independent associated factors for predicting the 5-year survival rate of patients (p = 0.026, 0.004, and <0.001, respectively). Age, T staging, and CLIC1 expression significantly correlated with the overall survival of post-operative lung adenocarcinoma patients. CLIC1 may be closely associated with the occurrence and development of lung adenocarcinoma and may be used as an effective marker for predicting the prognosis of this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858536     DOI: 10.1007/s13277-011-0223-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.

Authors:  Gillian Bethune; Drew Bethune; Neale Ridgway; Zhaolin Xu
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

2.  New molecular targeted therapies for advanced non-small-cell lung cancer.

Authors:  Míriam Méndez; Ana Custodio; Mariano Provencio
Journal:  J Thorac Dis       Date:  2011-03       Impact factor: 2.895

3.  Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src.

Authors:  V J Fincham; M James; M C Frame; S J Winder
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  CLIC1 protein: a candidate prognostic biomarker for malignant-transformed hydatidiform moles.

Authors:  Zhong-Hua Shi; Chun Zhao; Hong Wu; Wei Wang; Xiao-Mei Liu
Journal:  Int J Gynecol Cancer       Date:  2011-01       Impact factor: 3.437

5.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

6.  Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma.

Authors:  Ying-Hwa Chang; Chih-Ching Wu; Kai-Ping Chang; Jau-Song Yu; Yu-Chen Chang; Pao-Chi Liao
Journal:  J Proteome Res       Date:  2009-12       Impact factor: 4.466

7.  HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma.

Authors:  L Lo Muzio; R Leonardi; M A Mariggiò; M D Mignogna; C Rubini; A Vinella; G Pannone; L Giannetti; R Serpico; N F Testa; G De Rosa; S Staibano
Journal:  Histol Histopathol       Date:  2004-01       Impact factor: 2.303

8.  Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis.

Authors:  Takeshi Tomonaga; Kazuyuki Matsushita; Seiko Yamaguchi; Masamichi Oh-Ishi; Yoshio Kodera; Tadakazu Maeda; Hideaki Shimada; Takenori Ochiai; Fumio Nomura
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

9.  Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.

Authors:  Ottavio Rena; Luca Carsana; Silvia Cristina; Esther Papalia; Fabio Massera; Luca Errico; Cristina Bozzola; Caterina Casadio
Journal:  Eur J Cardiothorac Surg       Date:  2007-11-01       Impact factor: 4.191

10.  Interaction of Sedlin with PAM14.

Authors:  Xiaoying Liu; Yunfei Wang; Hengrui Zhu; Qinghui Zhang; Xin Xing; Biao Wu; Lihua Song; Libin Fan
Journal:  J Cell Biochem       Date:  2010-04-15       Impact factor: 4.429

View more
  21 in total

1.  Regulation of colon cancer cell migration and invasion by CLIC1-mediated RVD.

Authors:  Pan Wang; Chao Zhang; PeiWu Yu; Bo Tang; Tao Liu; Hao Cui; JianHua Xu
Journal:  Mol Cell Biochem       Date:  2012-03-17       Impact factor: 3.396

2.  CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.

Authors:  Yuguang Ye; Mingzhu Yin; Bihui Huang; Yaqi Wang; Xia Li; Ge Lou
Journal:  Tumour Biol       Date:  2015-01-13

3.  Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.

Authors:  Mark Kriegsmann; Rita Casadonte; Jörg Kriegsmann; Hendrik Dienemann; Peter Schirmacher; Jan Hendrik Kobarg; Kristina Schwamborn; Albrecht Stenzinger; Arne Warth; Wilko Weichert
Journal:  Mol Cell Proteomics       Date:  2016-07-29       Impact factor: 5.911

4.  Chloride intracellular channel 1 (CLIC1) is activated and functions as an oncogene in pancreatic cancer.

Authors:  Jianhua Lu; Qian Dong; Bingtai Zhang; Xuefeng Wang; Bin Ye; Fei Zhang; Xiaoling Song; Guofeng Gao; Jiasheng Mu; Zheng Wang; Fei Ma; Jun Gu
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

5.  Chloride intracellular channel 1 regulates colon cancer cell migration and invasion through ROS/ERK pathway.

Authors:  Pan Wang; Yun Zeng; Tao Liu; Chao Zhang; Pei-Wu Yu; Ying-Xue Hao; Hua-Xin Luo; Gang Liu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

6.  Video-assisted thoracoscopic lobectomy for non-small cell lung cancer in patients with severe chronic obstructive pulmonary disease.

Authors:  Wei Wang; Zhiqiang Xu; Xinguo Xiong; Weiqiang Yin; Xin Xu; Wenlong Shao; Hanzhang Chen; Jianxing He
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 7.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

8.  Relocation of CLIC1 promotes tumor cell invasion and colonization of fibrin.

Authors:  Lisa A Gurski; Lynn M Knowles; Per H Basse; Jodi K Maranchie; Simon C Watkins; Jan Pilch
Journal:  Mol Cancer Res       Date:  2014-09-09       Impact factor: 5.852

9.  CLIC1 overexpression is associated with poor prognosis in gallbladder cancer.

Authors:  Qichen Ding; Maolan Li; Xiangsong Wu; Lin Zhang; Wenguang Wu; Qian Ding; Hao Weng; Xu'an Wang; Yingbin Liu
Journal:  Tumour Biol       Date:  2014-09-17

10.  Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas.

Authors:  Liang Wang; Shiming He; Yanyang Tu; Peigang Ji; Jianhai Zong; Jingyu Zhang; Fuqiang Feng; Jipei Zhao; Yongsheng Zhang; Guodong Gao
Journal:  J Exp Clin Cancer Res       Date:  2012-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.